MIRA Pharmaceuticals, Inc. Share Price
MIRAMIRA Pharmaceuticals, Inc. Stock Performance
Open $0.99 | Prev. Close $0.96 | Circuit Range N/A |
Day Range $0.93 - $0.99 | Year Range $0.91 - $2.44 | Volume 1,236 |
Average Traded $0.97 |
MIRA Pharmaceuticals, Inc. Share Price Chart
About MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
MIRA Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
15-Jul-26 | $0.96 | $0.96 | +4.01% |
13-Jul-26 | $0.92 | $0.92 | +0.99% |
10-Jul-26 | $0.94 | $0.91 | +0.88% |
08-Jul-26 | $0.91 | $0.91 | -4.03% |
07-Jul-26 | $0.94 | $0.94 | +0.11% |
06-Jul-26 | $0.94 | $0.94 | -2.79% |
29-Jun-26 | $0.97 | $0.97 | -3.10% |